August, 2025
August 2025
M T W T F S S
 123
45678910
11121314151617
18192021222324
25262728293031
Roberto Ferrara: Neoadjuvant versus perioperative chemo-immunotherapy according to pathological response in resectable NSCLC
Apr 15, 2025, 07:09

Roberto Ferrara: Neoadjuvant versus perioperative chemo-immunotherapy according to pathological response in resectable NSCLC

Roberto Ferrara, Medical Oncologist,Researcher in Thoracic Oncology and Molecular Immunology at Vita-Salute San Raffaele University, posted on X about recent paper he and his colleagues co-authored:

“Time to tailor chemo-IO in resected NSCLC.

Reconstructed individual pts data show NEOAD= PERIOP in pCR, MPR, non-MPR. PERIOP performs well in pure-MPR (1-10%RVT). pCR or no-MPR deserve descalation or escalation strategies.”